94 related articles for article (PubMed ID: 16526059)
1. Caspase-dependent cleavage of 170-kDa P-glycoprotein during apoptosis of human T-lymphoblastoid CEM cells.
Mantovani I; Cappellini A; Tazzari PL; Papa V; Cocco L; Martelli AM
J Cell Physiol; 2006 Jun; 207(3):836-44. PubMed ID: 16526059
[TBL] [Abstract][Full Text] [Related]
2. Suberoylanilide hydroxamic acid (SAHA) overcomes multidrug resistance and induces cell death in P-glycoprotein-expressing cells.
Ruefli AA; Bernhard D; Tainton KM; Kofler R; Smyth MJ; Johnstone RW
Int J Cancer; 2002 May; 99(2):292-8. PubMed ID: 11979447
[TBL] [Abstract][Full Text] [Related]
3. LY294,002, a specific inhibitor of PI3K/Akt kinase pathway, antagonizes P-glycoprotein-mediated multidrug resistance.
Barancík M; Bohácová V; Sedlák J; Sulová Z; Breier A
Eur J Pharm Sci; 2006 Dec; 29(5):426-34. PubMed ID: 17010577
[TBL] [Abstract][Full Text] [Related]
4. The cyclin-dependent kinase inhibitor roscovitine and the nucleoside analog sangivamycin induce apoptosis in caspase-3 deficient breast cancer cells independent of caspase mediated P-glycoprotein cleavage: implications for therapy of drug resistant breast cancers.
Cappellini A; Chiarini F; Ognibene A; McCubrey JA; Martelli AM
Cell Cycle; 2009 May; 8(9):1421-5. PubMed ID: 19342873
[TBL] [Abstract][Full Text] [Related]
5. The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism.
Chiarini F; Del Sole M; Mongiorgi S; Gaboardi GC; Cappellini A; Mantovani I; Follo MY; McCubrey JA; Martelli AM
Leukemia; 2008 Jun; 22(6):1106-16. PubMed ID: 18385752
[TBL] [Abstract][Full Text] [Related]
6. Inhibitor of apoptosis protein hILP undergoes caspase-mediated cleavage during T lymphocyte apoptosis.
Johnson DE; Gastman BR; Wieckowski E; Wang GQ; Amoscato A; Delach SM; Rabinowich H
Cancer Res; 2000 Apr; 60(7):1818-23. PubMed ID: 10766165
[TBL] [Abstract][Full Text] [Related]
7. The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis.
Smyth MJ; Krasovskis E; Sutton VR; Johnstone RW
Proc Natl Acad Sci U S A; 1998 Jun; 95(12):7024-9. PubMed ID: 9618532
[TBL] [Abstract][Full Text] [Related]
8. P-glycoprotein expression does not change the apoptotic pathway induced by curcumin in HL-60 cells.
Bielak-Mijewska A; Piwocka K; Magalska A; Sikora E
Cancer Chemother Pharmacol; 2004 Feb; 53(2):179-85. PubMed ID: 14530869
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of P-glycoprotein: suppression of caspase activation in the absence of ATP-dependent drug efflux.
Tainton KM; Smyth MJ; Jackson JT; Tanner JE; Cerruti L; Jane SM; Darcy PK; Johnstone RW
Cell Death Differ; 2004 Sep; 11(9):1028-37. PubMed ID: 15131592
[TBL] [Abstract][Full Text] [Related]
10. Notch1 antiapoptotic activity is abrogated by caspase cleavage in dying T lymphocytes.
Cohen LY; Bourbonnière M; Sabbagh L; Bouchard A; Chew T; Jeannequin P; Lazure C; Sékaly RP
Cell Death Differ; 2005 Mar; 12(3):243-54. PubMed ID: 15650752
[TBL] [Abstract][Full Text] [Related]
11. Akt inhibition upregulates FasL, downregulates c-FLIPs and induces caspase-8-dependent cell death in Jurkat T lymphocytes.
Uriarte SM; Joshi-Barve S; Song Z; Sahoo R; Gobejishvili L; Jala VR; Haribabu B; McClain C; Barve S
Cell Death Differ; 2005 Mar; 12(3):233-42. PubMed ID: 15665818
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells.
Zhang XM; Lin H; Chen C; Chen BD
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):127-33. PubMed ID: 10229667
[TBL] [Abstract][Full Text] [Related]
13. Function of caspases in regulating apoptosis caused by erythropoietin deprivation in erythroid progenitors.
Gregoli PA; Bondurant MC
J Cell Physiol; 1999 Feb; 178(2):133-43. PubMed ID: 10048577
[TBL] [Abstract][Full Text] [Related]
14. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.
Asselin E; Mills GB; Tsang BK
Cancer Res; 2001 Mar; 61(5):1862-8. PubMed ID: 11280739
[TBL] [Abstract][Full Text] [Related]
15. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5.
Park SJ; Wu CH; Choi MR; Najafi F; Emami A; Safa AR
Biochem Pharmacol; 2006 Jul; 72(3):293-307. PubMed ID: 16753135
[TBL] [Abstract][Full Text] [Related]
16. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling.
Perchellet EM; Wang Y; Weber RL; Sperfslage BJ; Lou K; Crossland J; Hua DH; Perchellet JP
Biochem Pharmacol; 2004 Feb; 67(3):523-37. PubMed ID: 15037204
[TBL] [Abstract][Full Text] [Related]
17. P-glycoprotein inhibits caspase-8 activation but not formation of the death inducing signal complex (disc) following Fas ligation.
Ruefli AA; Tainton KM; Darcy PK; Smyth MJ; Johnstone RW
Cell Death Differ; 2002 Nov; 9(11):1266-72. PubMed ID: 12404126
[TBL] [Abstract][Full Text] [Related]
18. The caspase 9 inhibitor Z-LEHD-FMK protects human liver cells while permitting death of cancer cells exposed to tumor necrosis factor-related apoptosis-inducing ligand.
Ozoren N; Kim K; Burns TF; Dicker DT; Moscioni AD; El-Deiry WS
Cancer Res; 2000 Nov; 60(22):6259-65. PubMed ID: 11103780
[TBL] [Abstract][Full Text] [Related]
19. PAK2 is cleaved and activated during hyperosmotic shock-induced apoptosis via a caspase-dependent mechanism: evidence for the involvement of oxidative stress.
Chan WH; Yu JS; Yang SD
J Cell Physiol; 1999 Mar; 178(3):397-408. PubMed ID: 9989786
[TBL] [Abstract][Full Text] [Related]
20. KBH-A42, a histone deacetylase inhibitor, inhibits the growth of doxorubicin-resistant leukemia cells expressing P-glycoprotein.
Kang MR; Lee K; Kang JS; Lee CW; Lee KH; Kim JH; Yang JW; Kim BG; Han G; Kang JS; Park SK; Kim HM
Oncol Rep; 2010 Mar; 23(3):801-9. PubMed ID: 20127023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
